Variables | Outcome by program | ||||
---|---|---|---|---|---|
UTT (N, %) | CD4 based (N, %) | Total | |||
Died | Censored | Died | Censored | (N, %) | |
Mean age at DX | 35 ± 8.9 | 35.4 ± 9.3 | 35 ± 9.3 | ||
Mean weight | 53 ± 12 | 51 ± 10 | 52.16 ± 11.2 | ||
Sex | |||||
Male | 4 (33.3) | 76 (39.6) | 16 (44.5) | 68 (26) | 164 (32.8) |
Female | 8 (66.7) | 116 (60.4) | 20 (55.5) | 192 (74) | 336 (67.2) |
Residence | |||||
Rural | 8 (66.7) | 58 (30.2) | 28 (77.8) | 126 (48.5) | 220 (44) |
Urban | 4 (33.3) | 134 (69.8) | 8 (22.2) | 134 (51.5) | 280 (56) |
Marital status | |||||
Single | 2 (16.7) | 26 (13.5) | 2 (5) | 48 (18.5) | 78 (15.6) |
Married | 4 (33.3) | 110 (57.3) | 18 (50) | 132 (50.75) | 264 (52.8) |
Divorced | 6 (50) | 56 (29.2) | 16 (45) | 80 (30.75) | 158 (31.6) |
Educational status | |||||
Illiterate | 10 (83.3) | 64 (33.3) | 16 (44.5) | 94 (36) | 184 (36.8) |
Literate | 2 (16.7) | 128 (66.7) | 20 (55.5) | 166 (64) | 316 (63.2) |
WHO stage | |||||
Stage I | 0 (0) | 80 (41.6) | 4 (11.1) | 34 (13) | 118 (23.6) |
Stage II | 4 (33.3) | 64 (33.4) | 0 (0) | 60 (23) | 128 (25.6) |
Stage III | 8 (66.7) | 36 (18.75) | 30 (83.3) | 156 (60) | 230 (46) |
Stage IV | 0 (0) | 12 (6.25) | 2 (5.6) | 10 (4) | 24 (4.8) |
Median CD4 count | 257.5 (IQR: 129–560) | 182 (IQR: 110–234.5) | 198 (IQR: 125–302) | ||
Median time from diagnosis to Rx | 0.3 (IQR = 0.1–4.1) | 0.9 (IQR = 0.6–1.5) | 0.7 (IQR = 0.2–1.1) | ||
OIS | |||||
Yes | 4 (33.3) | 74 (38.5) | 24 (66.7) | 140 (53.8) | 242 (48.4) |
No | 8 (66.7) | 118 (61.5) | 12 (33.3) | 120 (46.2) | 258 (51.6) |
New OIS | |||||
Yes | 6 (50) | 18 (9.4) | 6 (16.7) | 10 (3.84) | 40 (1.6) |
No | 6 (50) | 174 (90.6) | 30 (83.3) | 250 (96.16) | 460 (98.4) |
Treatment failure | |||||
Yes | 8 (66.7) | 10 (5.2) | 10 (27.8) | 2 (0.8) | 30 (6) |
No | 4 (33.3) | 182 (94.8) | 26 (62.2) | 258 (99.2) | 470 (94) |
Treatment switch | |||||
Yes | 0 (0) | 2 (1) | 2 (5.5) | 4 (1.54) | 8 (1.6) |
No | 12 (100) | 190 (99) | 34 (94.5) | 256 (98.46) | 492 (98.4) |